Guardant Health (NASDAQ:GH) Given New $52.00 Price Target at Scotiabank
Guardant Health (NASDAQ:GH – Get Free Report) had its price objective boosted by analysts at Scotiabank from $47.00 to $52.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “sector outperform” rating on the stock. Scotiabank’s target price points to a potential upside of 28.87% from the stock’s current price. […]
Guardant Health (NASDAQ:GH – Get Free Report) had its price objective boosted by analysts at Scotiabank from $47.00 to $52.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “sector outperform” rating on the stock. Scotiabank’s target price points to a potential upside of 28.87% from the stock’s current price. […]
